|
JPH07506822A
(ja)
|
1992-05-19 |
1995-07-27 |
ノボゲン リサーチ ピーティーワイ リミッテッド |
フィト−エストロゲン，類似体またはその代謝産物を含有する健康補助剤
|
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
AUPO203996A0
(en)
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
|
JP2002506818A
(ja)
*
|
1998-03-17 |
2002-03-05 |
ワーナー−ランバート・カンパニー |
スタチン−マトリックスメタロプロテイナーゼ阻害剤組み合わせ物
|
|
AU3103800A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
|
|
AU2007200367B2
(en)
*
|
1999-02-06 |
2010-04-08 |
Astrazeneca Ab |
Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
|
|
GB0001662D0
(en)
|
1999-02-06 |
2000-03-15 |
Zeneca Ltd |
Pharmaceutical compositions
|
|
DK1216038T3
(da)
|
1999-08-30 |
2005-12-27 |
Sanofi Aventis Deutschland |
Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
|
|
AUPQ266199A0
(en)
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
|
DE19944803A1
(de)
*
|
1999-09-20 |
2001-03-29 |
Bayer Ag |
Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
|
|
US7125897B1
(en)
|
1999-09-24 |
2006-10-24 |
Vasogen Ireland Limited |
Combined therapies for atherosclerosis treatment
|
|
FR2803525B1
(fr)
*
|
2000-01-06 |
2002-05-03 |
Sod Conseils Rech Applic |
Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
|
|
AR030414A1
(es)
*
|
2000-04-03 |
2003-08-20 |
Astrazeneca Ab |
Combinacion farmaceutica que comprende un beta bloqueante y un inhibidor de hmg-coa reductasa , formulacion farmaceutica, equipo transportable de partes , uso de esta combinacion y de esta formulacion para preparar medicamentos
|
|
GB2361185A
(en)
|
2000-04-10 |
2001-10-17 |
Nicholas J Wald |
Pharmaceutical formulation for the prevention of cardiovascular disease
|
|
SE0002354D0
(sv)
*
|
2000-06-22 |
2000-06-22 |
Astrazeneca Ab |
New formulation
|
|
CZ303389B6
(cs)
|
2000-07-19 |
2012-08-29 |
Novartis Ag |
Sul valsartanu a farmaceutický prípravek obsahující tuto sul
|
|
EP1314425A4
(en)
*
|
2000-08-30 |
2004-06-02 |
Sankyo Co |
MEDICINAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
|
|
US7018649B2
(en)
*
|
2000-10-23 |
2006-03-28 |
Euro-Celtique, S.A. |
Felodipine transdermal device and methods
|
|
US8168616B1
(en)
|
2000-11-17 |
2012-05-01 |
Novartis Ag |
Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
|
|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
AUPR255401A0
(en)
*
|
2001-01-16 |
2001-02-08 |
Novogen Research Pty Ltd |
Regulation of lipids and/or bone density and compositions therefor
|
|
IL156445A0
(en)
|
2001-01-26 |
2004-01-04 |
Schering Corp |
Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
|
US7071181B2
(en)
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
|
KR20070120617A
(ko)
|
2001-01-26 |
2007-12-24 |
쉐링 코포레이션 |
치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
|
|
AUPR363301A0
(en)
|
2001-03-08 |
2001-04-05 |
Novogen Research Pty Ltd |
Dimeric isoflavones
|
|
OA12983A
(en)
*
|
2001-07-19 |
2006-10-13 |
Pharmacia Corp |
Combination of an aldosterone receptor antagonist and an HMG COA reductase inhibitor.
|
|
US20030114497A1
(en)
*
|
2001-07-31 |
2003-06-19 |
Laman Alani |
Pharmaceutical compositions of amlodipine and atorvastatin
|
|
US6852737B2
(en)
*
|
2001-08-06 |
2005-02-08 |
Recordati Ireland Limited |
Crude and crystalline forms of lercanidipine hydrochloride
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
US7056906B2
(en)
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
|
EP1429756B1
(en)
|
2001-09-21 |
2006-11-22 |
Schering Corporation |
Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
|
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
MXPA04006255A
(es)
|
2002-01-17 |
2004-09-27 |
Pharmacia Corp |
Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
|
|
JP2005533796A
(ja)
*
|
2002-06-20 |
2005-11-10 |
ザ・ガバナーズ・オブ・ザ・ユニバーシティ・オブ・アルバータ |
心臓保護薬または血行動態薬との併用におけるジクロロ酢酸塩
|
|
BR0312102A
(pt)
*
|
2002-06-27 |
2007-05-29 |
Sb Pharmco Inc |
sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento
|
|
CA2492084A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol hydobromide
|
|
US7071210B2
(en)
*
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
|
US20040053842A1
(en)
*
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
|
GB0221579D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Pfizer Ltd |
Combinations of atorvastatin and, adrenergic receptor antagonists
|
|
WO2004035051A1
(en)
*
|
2002-10-16 |
2004-04-29 |
Recordati Ireland Limited |
Lisinopril/lercanidipine combination therapy
|
|
CA2504916A1
(en)
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
|
|
WO2004081002A1
(en)
|
2003-03-07 |
2004-09-23 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
|
WO2004081004A1
(en)
|
2003-03-07 |
2004-09-23 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
DE602004018617D1
(de)
|
2003-03-07 |
2009-02-05 |
Schering Corp |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
|
GB0322552D0
(en)
|
2003-09-26 |
2003-10-29 |
Astrazeneca Uk Ltd |
Therapeutic treatment
|
|
EP1686967A4
(en)
*
|
2003-11-25 |
2012-08-08 |
Smithkline Beecham Cork Ltd |
CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
|
|
JP2007512372A
(ja)
*
|
2003-11-25 |
2007-05-17 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール塩、対応する組成物、送達および／または治療方法
|
|
JP5072364B2
(ja)
*
|
2003-11-25 |
2012-11-14 |
スミスクライン ビーチャム （コーク） リミテッド |
カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
|
|
KR20050092519A
(ko)
*
|
2004-03-16 |
2005-09-22 |
화이자 인코포레이티드 |
아토르바스타틴 및 α1-아드레날린성 수용체 길항제의 조합
|
|
US20070191438A1
(en)
*
|
2004-04-06 |
2007-08-16 |
Rohrer Susan P |
Methods for the treatment of hypertension
|
|
WO2005118166A2
(en)
|
2004-06-04 |
2005-12-15 |
Teva Pharmaceutical Industries, Ltd. |
Pharmaceutical composition containing irbesartan
|
|
JP2008510835A
(ja)
|
2004-08-25 |
2008-04-10 |
エッセンシャリス，インク． |
カリウムａｔｐチャンネル開放因子の製剤処方、及びその使用
|
|
CN101115480A
(zh)
*
|
2005-02-17 |
2008-01-30 |
奇斯药制品公司 |
马尼地平和他汀类药物的治疗组合
|
|
WO2007111027A1
(ja)
|
2006-03-29 |
2007-10-04 |
Kowa Co., Ltd. |
トリグリセリド低下剤及び高インスリン血症改善剤
|
|
WO2008054123A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Hanall Pharmaceutical Company, Ltd. |
Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
|
|
KR101209319B1
(ko)
|
2008-04-29 |
2012-12-06 |
한올바이오파마주식회사 |
안지오텐신-ⅱ-수용체 차단제를 포함하는 약제학적 제제
|
|
CZ2008740A3
(cs)
*
|
2008-11-24 |
2010-01-06 |
Zentiva, A.S. |
Pevná farmaceutická kompozice s úcinnými látkami atorvastatinem a telmisartanem
|
|
SG173044A1
(en)
*
|
2009-01-23 |
2011-08-29 |
Hanmi Holdings Co Ltd |
Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
|
|
SI23149A
(sl)
*
|
2009-09-21 |
2011-03-31 |
Silverstone Pharma |
Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
|
|
RU2481124C1
(ru)
*
|
2011-10-27 |
2013-05-10 |
Общество с ограниченной ответственностью "ВАЛЕНТА ИНТЕЛЛЕКТ" |
Фармацевтическая комбинация из аторвастатина и ницерголина для профилактики или лечения нарушений мозгового кровообращения
|
|
CN102671198A
(zh)
*
|
2011-12-17 |
2012-09-19 |
东莞达信生物技术有限公司 |
一种降压降脂复方药及其制备方法
|
|
KR20140028971A
(ko)
*
|
2012-08-31 |
2014-03-10 |
한미약품 주식회사 |
아토바스타틴, 이르베살탄 및 탄산마그네슘을 포함하는 이층정 복합제제
|
|
CA2903961A1
(en)
*
|
2013-03-12 |
2014-09-18 |
Lg Life Sciences Ltd. |
Complex preparation including valsartan and rosuvastatin calcium and manufacturing method therefor
|
|
CN104173420A
(zh)
*
|
2013-05-20 |
2014-12-03 |
广州诺氏刘生物科技有限公司 |
一种治疗急性肾衰竭的药物
|
|
KR102441249B1
(ko)
|
2014-10-23 |
2022-09-08 |
아레나 파마슈티칼스, 인크. |
Ｐｇｉ2 수용체 관련 병태의 치료 방법
|
|
KR20170003459A
(ko)
*
|
2015-06-30 |
2017-01-09 |
한미약품 주식회사 |
암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제
|
|
FR3040303B1
(fr)
*
|
2015-08-27 |
2019-04-05 |
Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger |
Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca
|
|
CN105232555A
(zh)
*
|
2015-11-19 |
2016-01-13 |
哈尔滨圣吉药业股份有限公司 |
一种替米沙坦/瑞舒伐他汀复方制剂及其制备方法
|
|
AU2017274438A1
(en)
*
|
2016-06-02 |
2018-12-13 |
Ana Pharmaceuticals, Inc. |
Methods and compositions for treatment of hypercalciuria and nephrolithiasis
|
|
US12521380B2
(en)
|
2017-01-25 |
2026-01-13 |
The George Institute for Global Health |
Compositions for the treatment of hypertension
|
|
HRP20230267T1
(hr)
|
2017-01-25 |
2023-06-09 |
The George Institute for Global Health |
Pripravci za liječenje hipertenzije
|
|
IL268997B2
(en)
|
2017-03-01 |
2023-09-01 |
Arena Pharm Inc |
Preparations containing pgi2 receptor agonists and processes for their preparation
|
|
US12433865B2
(en)
|
2018-05-16 |
2025-10-07 |
Arena Pharmaceuticals, Inc. |
Compositions comprising PGI2-receptor agonists and processes for the preparation thereof
|
|
JP7474738B2
(ja)
*
|
2018-07-26 |
2024-04-25 |
ザ ジョージ インスティテュート フォー グローバル ヘルス |
高血圧症の処置のための組成物
|
|
CN112826937B
(zh)
*
|
2021-03-25 |
2022-03-22 |
山东大学齐鲁医院 |
艾地苯醌与他汀类药物联用在防治动脉粥样硬化中的应用
|